Additionally, it was observed that PTEN-loss-mediated EMT causes upregulation of cancer stem cell (CSC) populations within tumor cells [54], which could mediate the reduced sensitivity to cisplatin, as CSCs are largely responsible for drug resistance in cancers [55]. Here, PTEN is linked to cancer.